Biomarker for diagnosis and prognosis of Multiple Sclerosis (MS)

Patent number:

EP24382907

No items found.

Countries:

Spain

Regions:

Community of Madrid

Centers:

CSIC, UNIVERSIDAD AUTONOMA DE MADRID, CIBERNED CENTRO DE INVESTIG BIOMEDICA EN RED ENFERMEDADES NEURODEGENERATIVAS

Other entities:

Sectors:

Health

Subsectors:

TRL Level:

TRL 4 – technology validated in lab

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

- Novel biomarker for diagnosis and prognosis - Minimally invasive method through blood or CFS extraction - Known molecular mechanism of action - Novel pre-clinical model for MS

Comments

Other related patents

Health

Functionalization of antimicrobial bioactive molecules on surfaces using silica coatings

Countries

Spain

Health

MOXIFLOXACIN FOR USE IN THE TREATMENT OF SPINAL MUSCULAR ATROPHY

Countries

Spain

Health

Therapeutic antibodies against SARS-CoV-2 based on camelid nanobodies

Countries

Spain

Get back to patents directory